Bisoprolol Fumarate And Hydrochlorothiazide Tablet, Film Coated
Product Images NDC 0378-0503

5 FDA label images from Mylan Pharmaceuticals Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Bisoprolol Fumarate And Hydrochlorothiazide (NDC 0378-0503). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Bisoprolol Fumarate Structural Formula (Image 01)

Bisoprolol Fumarate Structural Formula (Image 01)
Label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP 2.5 mg/6.25 mg, film-coated tablets manufactured by Mylan Pharmaceuticals Inc. The label shows the NDC 0378-0501-01, packaging for 100 tablets, and dosing details on the tablet strength. It includes storage instructions and a sample image of the peach-colored tablet marked with '501.'*
FDA Label Image

Hydrochlorothiazide Structural Formula (Image 02)

Hydrochlorothiazide Structural Formula (Image 02)
Label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, film-coated oral tablets with strengths of 5 mg bisoprolol fumarate and 6.25 mg hydrochlorothiazide. The label shows a white round tablet embossed with '503'. It is manufactured by Mylan Pharmaceuticals Inc. and comes in a 100-tablet bottle. Storage instructions and child-resistant container use are also indicated.*
FDA Label Image

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 2.5 mg/6.25 mg Bottle Label (Image 03)

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 2.5 mg/6.25 mg Bottle Label (Image 03)
Label for Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP 10 mg/6.25 mg, film-coated oral tablets manufactured by Mylan Pharmaceuticals Inc. The label includes the NDC 0378-0505-01, dosage strengths, a depiction of the tablet imprinted with '505', and storage instructions. The package contains 100 tablets and the label includes barcode and child-resistant container instructions.*
FDA Label Image

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 5 mg/6.25 mg Bottle Label (Image 04)

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 5 mg/6.25 mg Bottle Label (Image 04)
Packaging label for Bisoprolol Fumarate and Hydrochlorothiazide Tablets, USP, film-coated, containing 5 mg bisoprolol fumarate and 6.25 mg hydrochlorothiazide per tablet. The label indicates a package size of 100 tablets, distributed by Mylan Pharmaceuticals Inc., a Viatris company. Includes dosage warnings, storage instructions, barcode, NDC 0378-0503-01, and a designated varnish free area for variable data coding.*
FDA Label Image

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 10 mg/6.25 mg Bottle Label (Image 05)

Bisoprolol Fumarate And Hydrochlorothiazide Tablets 10 mg/6.25 mg Bottle Label (Image 05)
Packaging label for Bisoprolol Fumarate and Hydrochlorothiazide tablets, USP, 10 mg/6.25 mg strength. The film-coated tablets come in a bottle of 100 tablets. Label includes dosage ingredient details, storage instructions, distributor information (Mylan Pharmaceuticals Inc., Viatris), and barcodes. The product is indicated for prescription use only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.